Combined screening for preeclampsia and small for gestational age at 11-13 weeks.
about
Contemporary clinical management of the cerebral complications of preeclampsiaMelatonin for preventing pre-eclampsiaPlacental Protein 13 (PP13) - A Placental Immunoregulatory Galectin Protecting PregnancyPredictive factors for intrauterine growth restrictionPrediction of Small for Gestational Age Infants in Healthy Nulliparous Women Using Clinical and Ultrasound Risk Factors Combined with Early Pregnancy BiomarkersDiagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).First trimester aneuploidy screening program for preeclampsia prediction in a portuguese obstetric population.First-trimester uterine artery Doppler analysis in the prediction of later pregnancy complicationsMaternal Serum Screening Markers and Adverse Outcome: A New PerspectivePlacental DNA methylation at term reflects maternal serum levels of INHA and FN1, but not PAPPA, early in pregnancyRelationship between maternal hypoglycaemia and small-for-gestational-age infants according to maternal weight status: a retrospective cohort study in two hospitalsScreening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy.First trimester biomarkers in the prediction of later pregnancy complications.The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study.Cell-free DNA versus intact fetal cells for prenatal genetic diagnostics: what does the future hold?Thrombosis during pregnancy: Risks, prevention, and treatment for mother and fetus--harvesting the power of omic technology, biomarkers and in vitro or in vivo models to facilitate the treatment of thrombosis.The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study.Principles of first trimester screening in the age of non-invasive prenatal diagnosis: screening for other major defects and pregnancy complications.Impact of maternal serum levels of Visfatin, AFP, PAPP-A, sFlt-1 and PlGF at 11-13 weeks gestation on small for gestational age births.Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.Uterine Artery Doppler Flow Indices in Pregnant Women During the 11 Weeks + 0 Days and 13 Weeks + 6 Days Gestational Ages: a Study of 168 Patients.First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors.Association between first-trimester maternal serum pregnancy-associated plasma protein-A and obstetric complications.First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing.Comparative Study of Abdominal Versus Transvaginal Ultrasound for Uterine Artery Doppler Velocimetry at 11 to 13 Weeks.Risk Assessment at 11-14-Week Antenatal Visit: A Tertiary Referral Center Experience from South India.Uterine artery pulsatility index at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.Fetal major cardiac defects and placental dysfunction at 11-13 weeks' gestation.Early screening and prevention of preterm pre-eclampsia with aspirin: time for clinical implementation.Mid-pregnancy fetal biometry, uterine artery Doppler indices and maternal demographic characteristics: role in prediction of small-for-gestational-age birth.Uterine artery pulsatility index in the first trimester: assessment of intersonographer and intersampling site measurement differences.Endometrial vascularity is lower in pregnancies with pregnancy-induced hypertension or small-for-gestational-age fetus in live birth after in-vitro fertilization.Placental growth factor and pre-eclampsia.First-trimester screening for early and late small-for-gestational-age neonates using maternal serum biochemistry, blood pressure and uterine artery Doppler.First-trimester screening with specific algorithms for early- and late-onset fetal growth restriction.Maternal serum PAPP-A and free β-hCG at 12, 22 and 32 weeks' gestation in screening for pre-eclampsia.Placental syndromes: getting to the heart of the matter.Reference ranges for the uterine arteries Doppler and cervical length measurement at 11-13(+6) weeks of gestation in a Brazilian population.Second-trimester prediction of delivery of a small-for-gestational-age neonate: integrating sequential Doppler information, fetal biometry, and maternal characteristics.Differential performance of first-trimester screening in predicting small-for-gestational-age neonate or fetal growth restriction.
P2860
Q21128665-5F390F33-E396-4E48-960C-7D48A63F0E03Q24188340-3F6A5B34-FB4A-43C4-8637-1812BD7885F3Q26861380-31674030-DEA4-4257-8A96-F8F2CF0B6B6AQ26864872-878A14E0-FBD0-4F9F-8B6B-3C898408ED64Q28469496-A99A8A23-68AB-4E5B-AAE9-C304981F3E4FQ33579089-D8D02E0C-C7B1-4648-9E17-9387A9C99738Q33758710-4A9D881D-0069-45C9-A53B-FF7BEF011AF2Q35564184-09E34C12-0F54-4C43-865B-F879D7C65E6DQ35667145-B229EC64-905B-4D2E-A2ED-AA07DDBB0D37Q36366144-8AA2B9E9-4ABE-4DF0-82A2-4C75B6C4F9F9Q37516949-6F5612CB-0D92-42AA-BEB2-9B0D689E3845Q37620584-7D13F58D-6937-480F-941C-2D6A235A96B9Q37706433-17940FC4-73B3-4ED8-AE95-868F5E32BC9EQ38436237-9AF2A879-BD8B-4B5D-AECF-67EFDA836480Q38509263-10337400-611B-4F13-A81D-98811A1E4CD9Q38592484-1F6D1B54-C3A1-4964-B2F6-D90EBDC3AC03Q38664824-8B43BDC3-000F-4B48-81A2-7166F746DB29Q39429807-20D7CF45-EA35-47D8-BD00-8272412030F3Q39813910-D71BAB06-5FFF-47E1-8842-D49642EEA161Q40053463-043981E5-8D4F-4C0A-8536-455E19F5CEF6Q41541622-DF6D7998-1740-4123-BDBF-247894756D14Q43620907-FA0416E2-080A-4D3D-9A47-8CD8AFFA1C17Q43768827-0E187F6B-9E1F-48BA-8E15-506486B997EFQ43905798-895ABE96-8180-484C-AF5C-0FBE11A6D658Q47562332-857FF7A9-B87D-402E-9CDA-FD2D09AE66ADQ47798818-7DB37C8E-9BD3-457B-B029-9222D90F9F7AQ47815916-26CB3316-C538-4EA8-9F05-5461851ECD13Q47916114-CBE00FB1-D835-4145-AE9C-2AACAEE97019Q48099333-47EE91F4-EDFB-4DC0-81DB-BAF35C41F0E9Q48119162-936C0FE9-4967-4371-B6E7-817270CC9564Q48280474-64571906-4FB2-40BB-A7B4-28D585D51B88Q48609992-B4F26AC9-7EA1-4566-9ABD-159638EC41EFQ49546553-F18CFE48-5446-4635-87CE-0ED680AEA3E5Q50489891-F59E5F40-6269-46E0-B35B-FF1AF3304DFBQ50719310-940F56F8-29D3-4210-8EF0-EC0615D96C0AQ50744266-0A2462EF-A08A-40BD-979C-B4FEBEE5E9B6Q52929936-EC294BDD-2D55-4145-A24D-68015B88F214Q53302763-DB0049DD-E52B-48C7-985D-C39C60877C4AQ53842366-5793A3A1-E7DB-4CFA-903C-1AA55CD106C9Q55026595-81321D09-36D8-4ECB-8BDE-0FB09AB392E7
P2860
Combined screening for preeclampsia and small for gestational age at 11-13 weeks.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Combined screening for preeclampsia and small for gestational age at 11-13 weeks.
@en
Combined screening for preeclampsia and small for gestational age at 11-13 weeks.
@nl
type
label
Combined screening for preeclampsia and small for gestational age at 11-13 weeks.
@en
Combined screening for preeclampsia and small for gestational age at 11-13 weeks.
@nl
prefLabel
Combined screening for preeclampsia and small for gestational age at 11-13 weeks.
@en
Combined screening for preeclampsia and small for gestational age at 11-13 weeks.
@nl
P2093
P2860
P356
P1476
Combined screening for preeclampsia and small for gestational age at 11-13 weeks
@en
P2093
Jonathan Lai
Kypros H Nicolaides
Ranjit Akolekar
P2860
P356
10.1159/000341712
P577
2012-09-13T00:00:00Z